# PCGF1

## Overview
PCGF1 (Polycomb Group Ring Finger 1) is a gene that encodes a protein of the same name, which is a critical component of the Polycomb Repressive Complex 1 (PRC1). This protein is involved in chromatin remodeling and gene silencing, playing a pivotal role in transcriptional repression and developmental gene regulation. As a member of the variant PRC1 (vPRC1), PCGF1 is essential for maintaining pluripotency in stem cells and regulating differentiation in hematopoietic stem and progenitor cells (HSPCs). The protein interacts with various partners, including RING1B, BCOR, and KDM2B, to facilitate chromatin structure regulation and nucleosome deposition during DNA replication. These interactions underscore its importance in maintaining cellular identity and preventing inappropriate gene activation. Dysregulation of PCGF1 has been implicated in hematopoietic and myeloid malignancies, highlighting its clinical significance in maintaining normal cellular processes and preventing oncogenesis (Schaefer2021BCOR; Oliviero2015The; Takano2022PCGF1PRC1).

## Function
PCGF1 (Polycomb Group Ring Finger 1) is a component of the variant Polycomb Repressive Complex 1 (vPRC1), which plays a significant role in transcriptional repression and developmental gene regulation in healthy human cells. It is involved in maintaining pluripotency by interacting with a network of proteins associated with pluripotency, such as NANOG, OCT4, PATZ1, and DPPA4. This interaction suggests that PCGF1 is crucial for the expression of these genes and the maintenance of pluripotency (Oliviero2015The).

PCGF1 is also essential in hematopoietic stem and progenitor cells (HSPCs), where it prevents premature myeloid differentiation and maintains the differentiation potential of these cells. It achieves this by regulating chromatin structure and ensuring proper nucleosome deposition during DNA replication, which is crucial for gene repression (Takano2022PCGF1PRC1). PCGF1-PRC1 facilitates PRC2-mediated repression by promoting H3K27me3 deposition, although it does not affect PRC2 binding directly (Takano2022PCGF1PRC1).

In embryonic stem cells, PCGF1 is involved in the recruitment of RING1B to target genes during differentiation, which is essential for transcriptional repression (Sugishita2021Variant). PCGF1's role in chromatin remodeling and gene silencing is critical for maintaining cellular identity and preventing inappropriate gene activation (Takano2022PCGF1PRC1).

## Clinical Significance
Mutations and alterations in the expression of the PCGF1 gene have significant clinical implications, particularly in hematopoietic and myeloid malignancies. PCGF1 is a component of the Polycomb Repressive Complex 1 (PRC1), and its disruption can lead to aberrant gene expression and differentiation pathways. In hematopoietic cells, the absence of PCGF1 results in the upregulation of myeloid and stemness-related factors, such as Hmga2, which skews differentiation towards the myeloid lineage at the expense of B cell development. This imbalance can contribute to hematopoietic disorders (Takano2022PCGF1PRC1).

In myeloid malignancies, mutations in BCOR and BCORL1, which interact with PCGF1, lead to the disruption of the PRC1.1 complex. This disruption results in the derepression of target genes and activation of oncogenic signaling pathways, contributing to leukemia. Although PCGF1 mutations are rare in acute myeloid leukemia (AML), biallelic inactivation of PCGF1 mimics the effects of BCOR/BCORL1 mutations, highlighting its critical role in maintaining PRC1.1 function and preventing oncogenesis (Schaefer2021BCOR; Schaefer2022BCOR).

These findings suggest that PCGF1 plays a crucial role in maintaining normal cellular processes, and its dysregulation can lead to significant clinical consequences, particularly in blood-related disorders.

## Interactions
PCGF1 is a component of the Polycomb Repressive Complex 1 (PRC1) and participates in various protein interactions that are crucial for its function in chromatin remodeling and gene silencing. PCGF1 is part of the PRC1.1 complex, where it interacts exclusively with RING1B, indicating a specific role within this complex (Gao2012PCGF). It also associates with RYBP and YAF2, which are critical for PRC1 function (Gao2012PCGF).

In undifferentiated NT2 cells, PCGF1 forms a complex with KDM2B, BCOR, and other PRC1 components, suggesting its involvement in a pluripotency sub-network (Oliviero2015The). PCGF1 uniquely interacts with non-canonical PRC1 co-factors such as BCORL1 and SKP1, highlighting its role in non-canonical PRC1 complexes (Munawar2022Interplay). It also interacts with the CCR4-NOT complex, which is involved in E3 ligase activity and histone ubiquitination (Munawar2022Interplay).

PCGF1 is associated with DNA replication machinery, including DNA helicase complexes and histone chaperones, and plays a role in maintaining nucleosome density at gene promoters during DNA replication (Takano2022PCGF1PRC1). These interactions underscore PCGF1's multifaceted role in gene regulation and chromatin architecture.


## References


[1. (Takano2022PCGF1PRC1) Junichiro Takano, Shinsuke Ito, Yixing Dong, Jafar Sharif, Yaeko Nakajima-Takagi, Taichi Umeyama, Yong-Woon Han, Kyoichi Isono, Takashi Kondo, Yusuke Iizuka, Tomohiro Miyai, Yoko Koseki, Mika Ikegaya, Mizuki Sakihara, Manabu Nakayama, Osamu Ohara, Yoshinori Hasegawa, Kosuke Hashimoto, Erik Arner, Robert J. Klose, Atsushi Iwama, Haruhiko Koseki, and Tomokatsu Ikawa. Pcgf1-prc1 links chromatin repression with dna replication during hematopoietic cell lineage commitment. Nature Communications, November 2022. URL: http://dx.doi.org/10.1038/s41467-022-34856-8, doi:10.1038/s41467-022-34856-8. This article has 7 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-022-34856-8)

[2. (Sugishita2021Variant) Hiroki Sugishita, Takashi Kondo, Shinsuke Ito, Manabu Nakayama, Nayuta Yakushiji-Kaminatsui, Eiryo Kawakami, Yoko Koseki, Yasuhide Ohinata, Jafar Sharif, Mio Harachi, Neil P. Blackledge, Robert J. Klose, and Haruhiko Koseki. Variant pcgf1-prc1 links prc2 recruitment with differentiation-associated transcriptional inactivation at target genes. Nature Communications, September 2021. URL: http://dx.doi.org/10.1038/s41467-021-24894-z, doi:10.1038/s41467-021-24894-z. This article has 26 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-021-24894-z)

[3. (Gao2012PCGF) Zhonghua Gao, Jin Zhang, Roberto Bonasio, Francesco Strino, Ayana Sawai, Fabio Parisi, Yuval Kluger, and Danny Reinberg. Pcgf homologs, cbx proteins, and rybp define functionally distinct prc1 family complexes. Molecular Cell, 45(3):344–356, February 2012. URL: http://dx.doi.org/10.1016/j.molcel.2012.01.002, doi:10.1016/j.molcel.2012.01.002. This article has 715 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.molcel.2012.01.002)

[4. (Oliviero2015The) Giorgio Oliviero, Nayla Munawar, Ariane Watson, Gundula Streubel, Gwendolyn Manning, Vivian Bardwell, Adrian P. Bracken, and Gerard Cagney. The variant polycomb repressor complex 1 component pcgf1 interacts with a pluripotency sub-network that includes dppa4, a regulator of embryogenesis. Scientific Reports, December 2015. URL: http://dx.doi.org/10.1038/srep18388, doi:10.1038/srep18388. This article has 38 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/srep18388)

5. (Schaefer2021BCOR) BCOR and BCORL1 mutations disrupt PRC1.1 repressive function in leukemia by unlinking the RING-PCGF1 enzymatic core from target genes. This article has 0 citations.

[6. (Schaefer2022BCOR) Eva J. Schaefer, Helen C. Wang, Hannah Q. Karp, Clifford A. Meyer, Paloma Cejas, Micah D. Gearhart, Emmalee R. Adelman, Iman Fares, Annie Apffel, Klothilda Lim, Yingtian Xie, Christopher J. Gibson, Monica Schenone, H. Moses Murdock, Eunice S. Wang, Lukasz P. Gondek, Martin P. Carroll, Rahul S. Vedula, Eric S. Winer, Jacqueline S. Garcia, Richard M. Stone, Marlise R. Luskin, Steven A. Carr, Henry W. Long, Vivian J. Bardwell, Maria E. Figueroa, and R. Coleman Lindsley. Bcor and bcorl1 mutations drive epigenetic reprogramming and oncogenic signaling by unlinking prc1.1 from target genes. Blood Cancer Discovery, 3(2):116–135, March 2022. URL: http://dx.doi.org/10.1158/2643-3230.bcd-21-0115, doi:10.1158/2643-3230.bcd-21-0115. This article has 25 citations.](https://doi.org/10.1158/2643-3230.bcd-21-0115)

7. (Munawar2022Interplay) Interplay between Polycomb PCGF protein interactomes revealed by screening under endogenous conditions. This article has 0 citations.